buprenorphine hydrochloride and naloxone hydrochloride dihydrate
Active substance: NALOXONE HYDROCHLORIDE DIHYDRATE, BUPRENORPHINE HYDROCHLORIDE
TABLET · NALOXONE HYDROCHLORIDE DIHYDRATE .5 mg/1, BUPRENORPHINE HYDROCHLORIDE 2 mg/1
United StatesActive
Marketing holder: Golden State Medical Supply, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
Composition
- NALOXONE HYDROCHLORIDE DIHYDRATE · .5 mg/1
- BUPRENORPHINE HYDROCHLORIDE · 2 mg/1
Products containing naloxone in other countries
Showing products with this active substance, combinations included; the full composition is shown for each product.
| Country | Products |
|---|---|
| RU 12 |
|
| EU 3 |
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-c3bd-7a16-8ac8-56095ccce6e2,01a120c4-cfad-7a96-9553-cb40af9bd227,01a120c5-0297-7833-9575-faf4e14f80dc,01a120c5-a05f-74b4-b97c-1449409cfce3;count=4 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 51407-948
- Registration status
- Active
- Dispensing
- Prescription only
- Control marker
- CIII
- Route
- SUBLINGUAL
Sources
- product · openFDA NDC · 51407-948 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 51407-948 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 51407-948 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 51407-948 · Verified 2026-10-09 · open in source